Patent ID: 11866508
Assignee: AMGEN INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A  G | IPC A  C  G

Claim 19:
20. The method of claim 17, wherein the VH (MSLN) comprises CDRs 1-3 having the sequences set forth in SEQ ID NOs: 45, 46, and 47, respectively, the VL (MSLN) comprises CDRs 1-3 having the sequences set forth in SEQ ID NOs: 9, 10, and 11, respectively, the VH (CD3) comprises CDRs 1-3 having the sequences set forth in SEQ ID NOs: 115, 116, and 117, respectively, and the VL(CD3) comprises CDRs 1-3 having the sequences set forth in SEQ ID NOs: 112, 113, and 114, respectively.